NasdaqCM - Delayed Quote USD

Nexalin Technology, Inc. (NXL)

1.3850 -0.0350 (-2.46%)
At close: April 25 at 4:00 PM EDT
1.3702 -0.01 (-1.07%)
After hours: April 25 at 4:48 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Marilyn Elson Controller 382.72k -- 1953
Mr. Mark White President, CEO, CFO & Director 191.29k -- 1962
Mr. John Patrick Claude Co-Founder and Director of Engineering & Development -- -- --
Dr. David Owens M.D. Chief Medical Officer & Director -- -- 1961
Mr. Michael Nketiah Senior Vice-President of Quality, Regulatory & Clinical Affairs 251.6k -- 1976

Nexalin Technology, Inc.

1776 Yorktown
Suite 550
Houston, TX 77056
United States
832 260 0222 https://www.nexalin.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
6

Description

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.

Corporate Governance

Nexalin Technology, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Related Tickers

BTCY Biotricity, Inc.
1.3000
-6.47%
 
THMO ThermoGenesis Holdings, Inc.
0.6800
+4.62%
 
NUWE Nuwellis, Inc.
0.2890
+14.64%
 
BSGM BioSig Technologies, Inc.
1.3000
-1.52%
 
HSCS Heart Test Laboratories, Inc.
0.0999
-7.41%
 
AIMD Ainos, Inc.
1.0400
-0.95%
 
SINT Sintx Technologies, Inc.
0.0366
-5.43%
 
MDAI Spectral AI, Inc.
1.8400
-0.54%
 
COCH Envoy Medical, Inc.
5.06
+1.61%
 
DYNT Dynatronics Corporation
0.5754
-2.44%